4 Breakout stocks to watch closely 👀

Corporate earnings are at the top of today's watchlist, but these 4 stocks aren't waiting to take off.

Good Morning! 

It's Chris from Elite Trade Club, here to give you this morning's premarket trading news.

Let’s get ready to trade!

Markets 📈

Stocks posted solid but modest gains in their first day back from the weekend, extending Friday’s gains.

  • Dow [+0.3%]

  • S&P 500 [+0.3%]

  • Nasdaq [+0.3%]

  • Russell 2K [+0.7%]

Futures are sitting close to flat in early trading. S&P 500 contracts are currently down by less than 0.1%.

What to Watch Today:
It’s a huge day for earnings. This morning, we’ll hear from, Eli Lilly, McDonalds, Coca-Cola, and others, but the action really kicks off after the closing bell. The after-market earnings schedule features Amazon, AMD, Starbucks, and snack giant Mondelez. These reports will likely set the tone for both today’s and tomorrow’s trading session.

One small biotech holds the key to a revolution in treating Alzheimer's disease.

Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech.

Our research proves that anyone who gets in today could see 113,000% gains!

» Want an Ad-Free Experience + Top Growth Stock Picks? Upgrade Now!

Premarket Highlights 🔎

🎰Dave & Buster's Doubles-Down on Betting

Dave & Buster’s [PLAY], a leader in arcade and entertainment venues, is set to enhance the gaming experience for its customers by introducing the option to wager on arcade games.

This new feature will allow patrons to place $5 bets on popular games like Hot Shots basketball and Skee-Ball directly through the company's mobile app. Slated for launch in the upcoming months, this initiative taps into the growing trend of social wagering to elevate the traditional arcade experience.

New Chapter 🏗️ 
Founded in 1982, Dave & Buster's has expanded its footprint to over 222 venues across North America, offering a diverse array of activities including bowling, laser tag, and virtual reality. With a solid base of five million loyalty members and thirty million annual visitors, the company has seen its stock soar by more than 50% over the past year, reflecting its strong market presence and popularity.

Boosting Engagement 📈 
Inspired by the engaging impact of betting in sports, Dave & Buster’s aims to replicate this success within its venues. The betting feature is expected to foster a competitive spirit among players, encouraging them to spend more time and money, thereby driving up both engagement and revenue.

This move is seen as a strategic effort to adapt to changing consumer preferences, where digital and interactive experiences are highly valued.

Tech Partnership 🤝 
The betting functionality is powered by technology from Lucra, a notable gamification software company. Simon Murray, the Senior Vice President of Entertainment and Attractions at Dave & Buster’s, expressed excitement about the collaboration: "We’re thrilled to work with Lucra to bring this exciting new gaming platform to our customers. This new partnership gives our loyalty members real-time, unrivaled gaming experiences, and reinforces our commitment to continuing to elevate our customer experience through innovative, cutting-edge technology."

Looking Ahead 🚀 
Dave & Buster’s introduction of betting into arcade games marks a significant shift in the entertainment industry, promising to bring a fresh dynamism to the arcade scene. By merging technology with traditional gaming, the company is setting new standards in how entertainment businesses can innovate to enhance customer experiences and maintain relevance in a rapidly evolving digital age.

Featured Earnings 💰️ 

  • Eli Lilly And Company [LLY] ... AM

  • Coca-Cola Company [KO] ... AM

  • McDonald's [MCD] ... AM

  • Eaton Corporation [ETN] ... AM

  • American Tower [AMT] ... AM

  • Advanced Micro Devices [AMD] ... PM

  • Stryker [SYK] ... PM

  • Starbucks [SBUX] ... PM

  • Mondelez International [MDLZ] ... PM

  • Amazon.com [AMZN] ... PM

Economy 🏗

  • Employment cost index [Q1] ... 8:30a

  • S&P Case-Shiller home price index (20 cities) [Feb] ... 9:00a

  • Chicago Business Barometer (PMI) [Apr] ... 9:45a

  • Consumer confidence [Apr] ... 10:00a

Running Hot 🔥

  • Next eGo [EGOX] >> +40.5%

  • Auddia [AUUD] >> +26.0%

  • Warrantee [WRNT] >> +22.2%

  • Carnell Therapeutics [CTCX] >> (59.2%)

  • Medifast [MED] >> (19.4%)

  • Chegg [CHGG] >> (14.6%)

Genedx [WGS] - Last Close: $11.00

After yesterday’s closing bell, Genedx reported Q1 results that blew past analyst expectations and hiked its full-year 2024 guidance.

Genedx reported a loss of $(0.33) per share but beat the consensus of $(0.67). Sales of $62.422 million also topped the $49.463 million estimate.

The company said it now expects to generate sales ranging from $235 million to $245 million for FY2024, crushing the $226.1 million target.

Analysts at BTG maintained the stock at a “buy” and hiked its price target to $19 in response to the report.

WGS is up 24.8% on over 200K shares traded.

My Take: I’ve never heard of WGS before today, but, damn, its chart is pretty impressive. I’d like to see a little more volume, but it could find a new support level around $12 if it can hang on to its gains.

Mullen Automotive [MULN] - Last Close: $5.72

The micro-cap EV maker is surging after California’s Air Resources Board approved its 2024 Mullen THREE for its Hybrid and Zero-Emission Truck and Bus Voucher Incentive Project.

Mullen announced the breakthrough yesterday, and the news promptly rallied its shares to an 81.0% gain.

The rally is continuing in today’s premarket, with MULN up 16.4% on over 2.5 million shares traded.

My Take: MULN is getting a lot of attention from this report, but it’s hard to say whether this spike represents a trend shift or a merely a flash-in-the-pan rally.

Cyclacel Pharma [CYCC] - Last Close: $1.36

Cyclacel Pharma just announced an $8.0 million private placement priced at-the-market under Nasdaq rules.

The company plans to sell up to 4.96 million shares of common stock, plus accompanying warrants, priced at $1.61 apiece.

CYCC is up 58.8% on more than 5 million shares traded.

My Take: I expect we’ll see this move reverse course in the near future. CYCC is already locked in a major downtrend, and this won’t be enough to move the needle.

Marin Software [MRIN] - Last Close: $2.61

After Monday’s close, the tiny software developer announced the launch of a new AI-powered marketing tool, the Anamoly Detector.

Marin says the new tool can help marketers refine their online ad campaigns by automatically identifying and summarizing unexpected results in performance.

The Anamoly Detector also has the ability to analyze marketing campaigns across Google, Meta, Amazon, and other pay-per-click ad platforms.

MRIN is up 31.4% on nearly 3 million shares traded.

My Take: MRIN has been chalking up some wins lately, but it has been extremely volatile in the aftermath of its run-ups. Don’t be surprised if we see a bit of a pullback in the coming days.

That's it for today! Thanks for reading, and good luck out there!

Best Regards,

— Chris D.
Elite Trade Club

Text ELITE to 47121 or click here to get our alerts on your mobile device, and never miss another fast-moving stock!

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.

According to one early A.I. pioneer:

“You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”